Your browser doesn't support javascript.
loading
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies.
Tantalo, Daniela Gm; Oliver, Amanda J; von Scheidt, Bianca; Harrison, Aaron J; Mueller, Scott N; Kershaw, Michael H; Slaney, Clare Y.
Afiliação
  • Tantalo DG; Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Oliver AJ; Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • von Scheidt B; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Harrison AJ; Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Mueller SN; Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Kershaw MH; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Slaney CY; The Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The University of Melbourne, Melbourne, Victoria, Australia.
J Immunother Cancer ; 9(5)2021 05.
Article em En | MEDLINE | ID: mdl-34035114

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunoterapia Adotiva / Receptores de Antígenos Quiméricos / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunoterapia Adotiva / Receptores de Antígenos Quiméricos / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article